804555-44-0

Basic information

• Product Name: Benzenepropanoic acid, 2-[(1R)-1-[(2R)-oxiranylmethoxy]ethyl]-, methyl ester
• CAS NO: 804555-44-0
• Molecular Formula: C15H20O4
• Molecular Weight: 264.321
• Mol File: 804555-44-0.mol

Chemical Properties

• CAS DataBase Reference: Benzenepropanoic acid, 2-[(1R)-1-[(2R)-oxiranylmethoxy]ethyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenepropanoic acid, 2-[(1R)-1-[(2R)-oxiranylmethoxy]ethyl]-, methyl ester(804555-44-0)
• EPA Substance Registry System: Benzenepropanoic acid, 2-[(1R)-1-[(2R)-oxiranylmethoxy]ethyl]-, methyl ester(804555-44-0)

Safety Data

• Hazardous Substances Data: 804555-44-0(Hazardous Substances Data)

Upstream product

• 5411-56-3 (1R)-1-(2-bromophenyl)ethan-1-ol 
• 804555-43-9 C₁₅H₁₈O₄ 
• 787585-27-7 (2R)-2-{[(1R)-1-(2-bromo phenyl)ethoxy]methyl}oxirane 
• 1232828-91-9 methyl (2E)-3-(2-{(1R)-1-[(2R)-oxiran-2-yl methoxy]ethyl}phenyl)prop-2-enoate 

Relevant articles and documents

Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone

Short-acting oral calcilytics, calcium-sensing receptor (CaSR) antagonists, have been considered as alternatives for parathyroid hormone (PTH), an injectable bone anabolic drug used in the treatment of osteoporosis. Previously, we identified aminopropandi

CaSR ANTAGONIST

The present invention provides a compound having a calcium-sensitive receptor antagonistic action, a pharmaceutical composition containing the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis. A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the description.